echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > BMJ: Veritor and Biosensor rapid antigen detection can be used to detect the infectivity of close contacts 5 days after exposure

    BMJ: Veritor and Biosensor rapid antigen detection can be used to detect the infectivity of close contacts 5 days after exposure

    • Last Update: 2021-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The basis of control during the COVID-19 outbreak is the implementation of general infection control measures (hand hygiene, body distance, and staying at home when symptoms appear), combined with a testing and tracking plan
    .


    Mathematical modeling studies have shown that even assuming that at least 40% of the transmission may come from asymptomatic people or those who have not yet appeared, the detection and tracking program combined with general infection control measures can successfully control the new coronavirus epidemic


    The basis of control during the COVID-19 outbreak is the implementation of general infection control measures (hand hygiene, body distance, and staying at home when symptoms appear), combined with a testing and tracking plan


    A number of studies have now compared rapid antigen detection with RT-PCR detection


    Ewoud Schuit et al.


    Set up four public health service COVID-19 test points in the Netherlands
    .


    A total of 4274 close contacts of 16 years or older (identified through the testing and tracing program or contact tracing application) were collected, and they had no symptoms of new coronary pneumonia when the test was requested


    Set up four public health service COVID-19 test points in the Netherlands


    Among the 2678 participants tested by Veritor, 233 (8.


    The two rapid antigen tests have differently defined diagnostic accuracy variables for the positive reverse transcription polymerase chain reaction (RT-PCR) test based on viral load truncation, in which the viral load is lower than the viral load truncation threshold positive RT-PCR The test result is considered a negative result
    .

    The two rapid antigen tests have differently defined diagnostic accuracy variables for the positive reverse transcription polymerase chain reaction (RT-PCR) test based on viral load truncation, in which the viral load is lower than the viral load truncation threshold positive RT-PCR The test result is considered a negative result
    .


    When using viral load truncation (≥5.
    2 log10 new coronavirus E gene copy number/ml), the total sensitivity of Veritor and biosensor is 90.
    1% (84.
    2%-94.
    4%) and 86.
    8% in the asymptomatic patients.
    (78.
    1%~93.
    0%); The total sensitivity of Veritor and biosensor is 88.
    1% (80.
    5%~93.
    5%) and 85.
    1% (74.
    3%~92.
    6%), respectively
    .


    In all analyses, the specificity of the two rapid antigen tests was >99%, and the positive and negative predictive values ​​were >90% and >95%


    When using viral load truncation (≥5.


    The sensitivity of rapid antigen detection for asymptomatic and pre-symptomatic close contacts detected on the 5th day after close contact with a confirmed case is greater than 60%.


    Schuit E ,  Veldhuijzen I K ,  Venekamp R P ,  van den Bijllaardt W ,  Pas S D ,  Lodder E B  et al.


    Schuit E ,  Veldhuijzen I K ,  Venekamp R P ,  van den Bijllaardt W ,  Pas S D ,  Lodder E B  et al.
      Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study BMJ  2021 ;  374  :n1676  doi:10.
    1136/bmj.
    n1676        Schuit E ,  Veldhuijzen Veldhuijzen I K ,  Venekamp Venekamp R P ,  van den Bijllaardt   van den Bijllaardt W ,  Pas Pas S D ,  Lodder Lodder E B  et al.
      Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study BMJ  2021;  374  :n1676  BMJ  BMJ  2021 ;  374  :n1676  doi:10.
    1136/bmj.
    n1676 leave a message here    
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.